Ken Fisher's RMD Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 60.8K shares of ResMed Inc. (RMD) worth $16.64 M, representing 0.01% of the portfolio. First purchased in 2015-Q3, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Ken Fisher has maintained a long-term strategic position in RMD, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 18.4K shares. Largest reduction occurred in Q3 2023, reducing 46.2K shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's ResMed (RMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly ResMed (RMD) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2015 | +19,025 | New Buy | 19,025 | $50.99 |
| Q1 2016 | +1,925 | Add 10.12% | 20,950 | $59.76 |
| Q3 2017 | -3,500 | Reduce 16.71% | 17,450 | $76.96 |
| Q1 2018 | -17,450 | Sold Out | 17,450 | $0.00 |
| Q2 2020 | +35,895 | New Buy | 35,895 | $192.00 |
| Q3 2020 | -9 | Reduce 0.03% | 35,886 | $171.43 |
| Q4 2020 | +263 | Add 0.73% | 36,149 | $212.56 |
| Q1 2021 | +156 | Add 0.43% | 36,305 | $194.02 |
| Q2 2021 | +8,224 | Add 22.65% | 44,529 | $246.51 |
| Q3 2021 | +11,234 | Add 25.23% | 55,763 | $263.56 |
| Q4 2021 | +5,013 | Add 8.99% | 60,776 | $260.48 |
| Q1 2022 | +6,826 | Add 11.23% | 67,602 | $242.51 |
| Q2 2022 | +1,476 | Add 2.18% | 69,078 | $209.63 |
| Q3 2022 | -7 | Reduce 0.01% | 69,071 | $218.30 |
| Q4 2022 | -2,494 | Reduce 3.61% | 66,577 | $208.13 |
| Q1 2023 | -2,758 | Reduce 4.14% | 63,819 | $218.99 |
| Q2 2023 | +1,714 | Add 2.69% | 65,533 | $218.50 |
| Q3 2023 | -46,161 | Reduce 70.44% | 19,372 | $147.87 |
| Q4 2023 | +3,479 | Add 17.96% | 22,851 | $172.02 |
| Q1 2024 | +1,416 | Add 6.20% | 24,267 | $198.04 |
| Q2 2024 | +897 | Add 3.70% | 25,164 | $191.42 |
| Q3 2024 | +1,563 | Add 6.21% | 26,727 | $244.12 |
| Q4 2024 | +16,301 | Add 60.99% | 43,028 | $228.69 |
| Q1 2025 | +3,430 | Add 7.97% | 46,458 | $223.85 |
| Q2 2025 | +315 | Add 0.68% | 46,773 | $258.00 |
| Q3 2025 | +14,011 | Add 29.96% | 60,784 | $273.73 |
Ken Fisher's ResMed Investment FAQs
Ken Fisher first purchased ResMed Inc. (RMD) in Q3 2015, acquiring 19,025 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held ResMed Inc. (RMD) for 41 quarters since Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to ResMed Inc. (RMD) was in Q2 2020, adding 35,895 shares worth $6.89 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 60,784 shares of ResMed Inc. (RMD), valued at approximately $16.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ResMed Inc. (RMD) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in ResMed Inc. (RMD) was 69,078 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.